GSTC
Price:
$0.0001
Market Cap:
$124.11K
GlobeStar Therapeutics Corporation is a clinical-stage biopharmaceutical firm dedicated to advancing proprietary drug formulations. These innovative treatments specifically target multiple sclerosis (MS) and various other neurodegenerative disorders. Established in 2016, the company was formerly known as AngioSoma, Inc., rebranding to GlobeStar Therapeutics Corporation in July 2021. Its operations are headquartered in Richland, Washington.
Industry
Biotechnology
IPO Date
2011-09-26
Stock Exchange
OTC
Ticker
GSTC
According to GlobeStar Therapeutics Corporation’s latest financial reports and current stock price. The company's current ROE is 148.30%. This represents a change of 900.66% compared to the average of 14.82% of the last 4 quarters.
The mean historical ROE of GlobeStar Therapeutics Corporation over the last ten years is -485.36%. The current 148.30% ROE has changed -130.55% with respect to the historical average. Over the past ten years (40 quarters), GSTC's ROE was at its highest in in the June 2021 quarter at 718.56%. The ROE was at its lowest in in the September 2015 quarter at -2287.71%.
Average
-485.36%
Median
130.25%
Minimum
-8591.09%
Maximum
1.35%
Discovering the peaks and valleys of GlobeStar Therapeutics Corporation ROE, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.
Maximum Annual Increase = 1.54%
Maximum Annual ROE = 1.35%
Minimum Annual Increase = -820.65%
Minimum Annual ROE = -8591.09%
| Year | ROE | Change |
|---|---|---|
| 2023 | 135.93% | 9.12% |
| 2022 | 124.56% | -90.78% |
| 2021 | 1.35% | 1.54% |
| 2020 | 82.22% | -16.51% |
| 2019 | 98.48% | 4.95% |
| 2018 | 93.83% | -65.15% |
| 2017 | 269.24% | -31.07% |
| 2016 | 390.59% | -104.55% |
| 2015 | -8591.09% | -820.65% |
| 2014 | 1.19% | -409.06% |
The current ROE of GlobeStar Therapeutics Corporation (GSTC) is less than than its 3-year, less than than its 5-year, and greater than its 10-year historical averages
3-year avg
536.99%
5-year avg
358.33%
10-year avg
-485.36%
GlobeStar Therapeutics Corporation’s ROE is less than GB Sciences, Inc. (28.02%), less than IR Biosciences Holdings Inc. (47.28%), less than Regnum Corp. (101.39%), less than Hard to Treat Diseases Inc. (0%), greater than Ampio Pharmaceuticals, Inc. (-113.96%), less than Bioasis Technologies Inc. (392.02%), less than Ehouse Global, Inc. (408.74%), greater than Scorpius Holdings, Inc. (0.00%), less than Panbela Therapeutics, Inc. (396.00%), greater than Acusphere, Inc. (-130.75%),
| Company | ROE | Market cap |
|---|---|---|
| 28.02% | $122.12K | |
| 47.28% | $128.12K | |
| 101.39% | $2.29K | |
| 0% | $109.65K | |
| -113.96% | $207.88K | |
| 392.02% | $7.94K | |
| 408.74% | $10.13K | |
| 0.00% | $4.96K | |
| 396.00% | $53.89K | |
| -130.75% | $49.00 |
One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like GlobeStar Therapeutics Corporation using the financials and key metrics that matter to you in a single view.
The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:
Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.
Get your free trial here.
The easiest way to analyze a company like GlobeStar Therapeutics Corporation or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.
Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.
Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.
What is the ROE?
How can you use the ROE?
What is GlobeStar Therapeutics Corporation's ROE?
How is the ROE calculated for GlobeStar Therapeutics Corporation (GSTC)?
What is the highest ROE for GlobeStar Therapeutics Corporation (GSTC)?
What is the 3-year average ROE for GlobeStar Therapeutics Corporation (GSTC)?
What is the 5-year average ROE for GlobeStar Therapeutics Corporation (GSTC)?
How does the current ROE for GlobeStar Therapeutics Corporation (GSTC) compare to its historical average?